- COVID-19 is primarily infecting older patients with comorbid conditions such as diabetes and cardiac disease.
- Children so far have experienced milder symptoms.
- Pregnant women who have been infected have also had a milder effect.
- The median duration between onset of symptoms and admission to the ICU is around 9 to 10 days.
- Primary reasons for ICU admission have been respiratory support. Two-thirds of patients have met the criteria for ARDS.
- Rapid access to diagnostic testing continues to be a priority as it enables clinicians to take action and implement infection control practices.
- The principal feature of those suffering from serious disease from COVID-10 is the development of ARDS.
- Treatment strategies for such patients include conservative fluid strategies for patients without shock following initial resuscitation, early antibiotics if bacterial co-infection is suspected, lung-protective ventilation, prone positioning, and ECMO for refractory hypoxaemia.
- Septic shock and specific organ dysfunction are also being observed in a significant proportion of patients with COVID-19-related critical illness.
- A large majority of severely affected patients have received targeted therapies, including neuraminidase inhibitors and corticosteroids.
- Mortality among all infected patients remains between 0.5% to 4%, but among those who have to be hospitalised, mortality is around 5 to 15%. Mortality rates are between 22 to 62% among those who become critically ill.
- The exact cause of death remains unknown, but presumed reasons include progressive hypoxia and multiorgan dysfunction.
- Additional critical care strategies are also being implemented including admission of patients with suspected infection to private rooms, use of face masks during assessment and transfer, maintaining a distance of at least 2 m between patients, extra caution when using high-flow nasal oxygen or non-invasive ventilation, and additional airborne precautions including N95 respirators and eye protection.
- Critical care facilities are also ensuring their staff receives updated training in infection prevention and control, including the use of protective equipment.
#CoronavirusOutbreak: Caring for the Critically Ill - Trends, Treatment and Mortality
Published on : Mon, 16 Mar 2020
The VITROS ® 3600 Immunodiagnostics System has been designed to help you effectively deliver a broad portfolio of high value immunoassay results. The VITROS ® 3600 System also offers Intelligent Sample Management, with the ability to prioritize...
Dual-lumen Jejunal Feeding Tube with Integrated Gastric Drainage Clinical Performance Compat Stayput is designed to be able to be placed using a variety of placement techniques at/or beyond the Ligament of Treitz. Nurse Convenience...
OUR NANOFLUIDIC TECHNOLOGY REVOLUTIONISES POINT-OF-CARE IN VITRO DIAGNOSTIC SOLUTIONS Abionic’s nanotechnology is transforming today’s blood-testing standards by bringing laboratory quality to near-patient testing and simultaneously analysing...
The New Definition of Simplicity for Critical Care Testing Measures: pH PCO 2 PO 2 Na K Cl iCa Glu Lac Hct Stat Profile Prime combines the revolutionary microelectronics
Developed for long-term lung support - approved for 29 days of use Elementary features: • Proven reliability and safety • Certified for 29 days application period • Matching pump sizes for ¼ "" or 3/8"" tubing • x.ellence, a multi-layer coating...